Mirabegron 2 mg | 99.14%
TargetMol
Mirabegron is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome.
More Information Supplier PageMirabegron
Search Results
Mirabegron 1 mg | 99.14%
TargetMol
Mirabegron is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome.
More Information Supplier PageMirabegron
Pentamidine isethionate 200 mg | 99.50%
TargetMol
Pentamidine isethionate is a synthetic amidine derivative, Pentamidine Isethionate is an antiprotozoal and antifungal agent.
More Information Supplier PagePentamidine isethionate
H-ASP-PHE-OH 200 mg | Purity Not Available
TargetMol
Pimobendan 2 mg | 99.84%
TargetMol
Pimobendan 25 mg | 99.84%
TargetMol
kb-NB77-78 25 mg | Purity Not Available
TargetMol
kb-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673(PKD1 inhibitor).
More Information Supplier Pagekb-NB77-78
kb-NB77-78 5 mg | Purity Not Available
TargetMol
kb-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673(PKD1 inhibitor).
More Information Supplier Pagekb-NB77-78
IDO-IN-7 100 mg | 99.87%
TargetMol
IDO-IN-7 (NLG-919 analogue) is a potent IDO (indoleamine-(2, 3)-dioxygenase) pathway inhibitor.
More Information Supplier PageIDO-IN-7
Ataluren 25 mg | Purity Not Available
TargetMol
Ataluren is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk.
More Information Supplier PageAtaluren
